Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease
Between 10 and 25% of individuals with non-alcoholic fatty liver disease (NAFLD) develop hepatic fibrosis leading to cirrhosis and hepatocellular carcinoma (HCC). To investigate the molecular basis of disease progression, we performed a genome-wide analysis of copy number variation (CNV) in a total...
Published in: | PLoS ONE |
---|---|
Main Author: | Zain S.M.; Mohamed R.; Cooper D.N.; Razali R.; Rampal S.; Mahadeva S.; Chan W.-K.; Anwar A.; Rosli N.S.M.; Mahfudz A.S.; Cheah P.-L.; Basu R.C.; Mohamed Z. |
Format: | Article |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899755032&doi=10.1371%2fjournal.pone.0095604&partnerID=40&md5=96173d91075e7825eab37a3218438a48 |
Similar Items
-
Non-alcoholic fatty liver disease and obesity among adult donors are major challenges to living-donor liver transplantation: A single-center experience
by: Rajaram R.B.; Jayaraman T.; Yoong B.-K.; Koh P.-S.; Loh P.S.; Koong J.-K.; Khalil A.A.; Md Hashim N.H.; Jamaluddin F.H.; Mahadeva S.
Published: (2022) -
A genome-wide characterization of copy number variations in native populations of Peninsular Malaysia
by: Fu R.; Mokhtar S.S.; Phipps M.E.; Hoh B.-P.; Xu S.
Published: (2018) -
Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
by: Miptah H.N.; Ramli A.S.; Mohamad M.; Hashim H.; Tharek Z.
Published: (2020) -
The Current Landscape of CRISPR-Cas9-based Technologies for Imaging of Genomic Loci in Fixed and Live Cells
by: Yu C.Y.; Yean C.Y.; Chan K.G.; Ang G.Y.
Published: (2024) -
Preventive mechanisms of Chinese Tibetan medicine Triphala against nonalcoholic fatty liver disease
by: Jiang Y.; Zhao L.; Ma J.; Yang Y.; Zhang B.; Xu J.; Dhondrup R.; Wong T.W.; Zhang D.
Published: (2024)